References
1.Hill ID, Dirks MH, Liptak GS, Colletti RB, Fasano A, Guandalini S, et al; North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2005;40(1):1-19.
2.Polanco I. Celiac disease. J Pediatr Gastroenterol Nutr. 2008; 47(Suppl1):S3 6.
3.Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, Schuppan D. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med. 1997;3(7):797-801.
4.Husby S, Koletzko S, Korponay-Szabo IR, Mearin ML, Phillips A, Shamir R, et al; European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. European Society for Pediactric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of celiac disease. J Pediatr Gastroenterol Nutr. 2012;54(4):136-60.
5.Villanacci V, Ceppa P, Tavani E, Vindigni C, Volta U; Gruppo Italiano Patologi Apparato Digerente (GIPAD); Società Italiana di Anatomia Patologica e Citopatologia Diagnostica/International Academy of Pathology, Italian division (SIAPEC/IAP). Coeliac disease: the histology report. Dig Liver Dis. 2011;43(Suppl 4):S385-95.
6.Rosén A, Sandström O, Carlsson A, Högberg L, Olén O, Stenlund H, et al. Usefulness of Symptoms to Screen for Celiac Disease. Pediatrics. 2014;133(2):211-8.
7.McGowan KE, Castiglione DA, Butzner JD. The Changing Face of Childhood Celiac Disease in North America: Impact of Serological Testing. Pediatrics. 2009;124(6):1572-8.
8.Auricchio S, Mazzacca G, Tosi R, Visakorpi J, Maki M, Polanco I. Coeliac disease as a family condition: identification of asymptomatic patients within family groups. Gastroenterology. 1988;1:25-31.
9.West J, Fleming KM, Tata LJ, Card TR, Crooks CJ. Incidence and prevalence of celiac disease and dermatitis herpetiformis in the UK over two decades: population-based study. Am J Gastroenterol. 2014;109(5):757-68.
10.Dubé C, Rostom A, Sy R, Cranney A, Saloojee N, Garritty C, et al. The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology. 2005;128(4Suppl1):S57-67.
11.López-Rodriguez MJ, Canal Macías ML, Lavado-García JM, Sánchez Belda M, Robledo Andrés P, Pedrera Zamorano JD. Epidemiological changes in diagnosed coeliac disease in a population of Spanish children. Acta Paediatr. 2003; 92(2):165-9.
12.Volta U, Villanacci V. Celiac disease:diagnostic criteria in progress. Cell Mol Immunol. 2011;8(2):96-102.
13.Sugai E, Vazquez H, Nachman F, Moreno ML, Mazure R, Smecuol E, et al. Accuracy of testing for antibodies to synthetic gliadin-related peptidesin celiac disease. Clin Gastroenetrol Hepatol. 2006;4(9):1112-7.
14. Agardh D. Antibodies against synthetic deamidated gliadin peptides and tissue transglutaminase for the identification of childhood celiac disease. Clin Gastroenterol Hepatol. 2007;5(11):1276-81.
15.Kaulinen K, Collin P, Laurila K, Kaartinen T, Partanen J, Mäki M. Resurrection of gliadin antibodies in celiac disease. Deamidated gliadin peptide antibody test provides additional diagnostic benefit. Scand J Gastroenterol. 2007;42(12):1428-33.
16.Niveloni S, Sugai E, Cabanne E, Vazquez H, Argonz J, Smecuol E, et al. Antibodies against synthetic deamidated gliadin peptides as predictors of celiac disease: prospective assessment in an adult population with a high pretest probabbility of disease. Clin Chem. 2007;53(12):2186-92.
17.Volta U, Granito A, Fiorini E, Parisi C, Piscaglia M, Pappas G, et al. Usefulness of antibodies to deamidated gliadin peptides in celiac disease diagnosis and follow-up. Dig Dis Sci. 2008;53(6):1582-8.
18.Mozo L, Gómez J, Escanlar E, Bousoño C, Gutiérrez C. Diagnostic value of anti-deamidated gliadin peptide IgG antibodies for celiac disease in children and IgA deficient patients. J Pediatr Gastroeneterol Nutr. 2012;55(1):50-5.
19. Olen O, Gudjónsdóttir AH, Browaldh L, Hessami M, Elvin K, Liedberg AS, et al. Antibodies against deamidated gliadin peptides and tissue transglutaminase for diagnosis of pediatric celiac disease. J Pediatr Gastroenterol Nutr. 2012;55(6):695-700.
20. Molberg O, Mcadam SN, Körner R, Quarsten H, Kristiansen C, Madsen L, et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med. 1998;4(6):713-7.
21. Schwertz E, Kahlenberg F, Sack U, Richter T, Stern M, Conrad K, et al. Serologic assay based on gliadin-related nonapeptides as a highly sensitive and specific diagnostic aid in celiac disease. Clin Chem. 2004;50(12):2370-5.
22.Giersiepen K, Lelgemann M, Stuhldreher N, Ronfani L, Husby S, Koletzko S, et al; ESPGHAN Working Group on Coeliac Disease Diagnosis. Accuracy of diagnostic antibody tests for coeliac disease in children: summary of an evidence report. J Pediatr Gastroenterol Nutr. 2012;54(2):229-41.
23.Bienvenu F, Besson Duvanel C, Seignovert C, Rouzaire P, Lachaux A, Bienvenu J. Evaluation of a point-of-care test based on deamidated gliadin peptides for celiac disease screening in a large pediatric population. Eur J Gastroenterol Hepatol. 2012;24(12):1418-23.
24.Marti CO, Fellay B, Bürgin-Wolff A, Magnin JL, Baehler P. Evaluation of a DGP point-of-care test for celiac disease in a pediatric population. International Journal of Celiac Disease. 2015;3(1):XX. DOI:10.12691/ijcd-3-1-8. Available online at http://pubs.sciepub.com/ijcd/3/1/8.
25.Bienvenu F, Anghel SI, Besson-Duvanel C, Guillemaud J, Garnier L, Renosi F, et al. Early diagnosis of celiac disease in IgA deficient children: contribution of a point-of-care test. BMC Gastroenterology. 2014;6(14):186. doi: 10.1186/1471-230X-14-186.
26.Benkebil F, Combescure C, Anghel SI, Besson Duvanel C, Schäppi MG. Diagnostic accuracy of a new point-of-care screening assay for celiac disease. World J Gastroenterol. 2013;19(31):5111-7.
27.Hong YY, Kiat C, Byrnes V. Anti-deamidated gliadin peptides rapid test (SIMTOMAX) as a simple and quick measure of compliance to gluten free diet in patients with celiac disease. Gut. 2013;62(Suppl2):A1-50.
28.Mooney PD, Kurien M, Evans KE, Chalkiadakis I, Hale MF, Kannan MZ, et al. Point-of care testing for celiac disease has a low sensitivity in endoscopy. Gastrointest Endosc. 2014;80(3):456-62.
29.Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol. 1999;11(10):1185-94.
30.Kurppa K, Lindfors K, Collin P, Saavalainen P, Partanen J, Haimila K, et al. Antibodies against deamidated gliadin peptides in early-stage celiac disease. J Clin Gastroenterol. 2011;45(8):673-8.
31.Cronin CC, Feighery A, Ferriss JB, Liddy C, Shanahan F, Feighery C. High prevalence of celiac disease among patients with insulin-dependent (type I) diabetes mellitus. Am J Gastroenterol. 1997;92(12):2210-2.
32. Peretti N, Bienvenu F, Bouvet C, Fabien N, Tixier F, Thivolet C, et al. The temporal relationship between the onset of type 1 diabetes and celiac disease: a study based on immunoglobulin a antitransglutaminase screening. Pediatrics. 2004;113(5):e418 22.
33.Mooney PD, Wong SH, Johnston AJ, Kurien M, Avgerinos A, Sanders DS. Increased Detection of Celiac Disease With Measurement of Deamidated Gliadin Peptide Antibody Before Endoscopy. Clin Gastroenterol Hepatol. 2015;13(7):1278-84.